Astrazeneca Pharma India Ltd
₹5957
+6.50 (0.11%)
Thu, 22 Oct 2026, 07:44 pm
Health Technology
Pharmaceuticals: Major
24.5KAstrazeneca Pharma India Shareholding
| Shareholders | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 |
|---|---|---|---|---|---|
| Promoters | 75 | 75 | 75 | 75 | 75 |
| FII | 2.68 | 2.78 | 2.71 | 2.74 | 3.03 |
| DII | 6.08 | 5.80 | 5.56 | 5.26 | 4.56 |
| Public | 16.24 | 16.42 | 16.73 | 17.00 | 17.41 |
| Government | 0 | 0 | 0 | 0 | 0 |
Astrazeneca Pharma India Ltd Shareholding Pattern
The Astrazeneca Pharma India Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Astrazeneca Pharma India Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Astrazeneca Pharma India Ltd (NSE: ASTRAZEN, BSE: 506820) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Astrazeneca Pharma India Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Astrazeneca Pharma India Ltd Shareholding Pattern (Latest)
The latest Astrazeneca Pharma India Ltd shareholding for Jun 2026 is:
- Promoters: 75%
- FII: 2.68%
- DII: 6.08%
- Public: 16.24%
- Government: 0%
Promoter holding in Astrazeneca Pharma India Ltd remains stable, reflecting consistent long-term commitment.
Astrazeneca Pharma India Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Astrazeneca Pharma India Ltd.
- Jun 2026: 75%
- Mar 2026: 75%
- Dec 2025: 75%
- Sept 2025: 75%
- Jun 2025: 75%
Promoter stake remains largely stable, showing consistent ownership structure.
Astrazeneca Pharma India Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Astrazeneca Pharma India Ltd.
- Jun 2026: 2.68%
- Mar 2026: 2.78%
- Dec 2025: 2.71%
- Sept 2025: 2.74%
- Jun 2025: 3.03%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Astrazeneca Pharma India Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Jun 2026: 6.08%
- Mar 2026: 5.80%
- Dec 2025: 5.56%
- Sept 2025: 5.26%
- Jun 2025: 4.56%
DII stake in Astrazeneca Pharma India Ltd has increased over time, indicating growing domestic institutional confidence.
Astrazeneca Pharma India Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Jun 2026: 16.24%
- Mar 2026: 16.42%
- Dec 2025: 16.73%
- Sept 2025: 17.00%
- Jun 2025: 17.41%
Public holding remains stable with consistent retail participation.
Astrazeneca Pharma India Ltd Government Holding
Government holding in Astrazeneca Pharma India Ltd currently stands at 0%.
Astrazeneca Pharma India Ltd operates without significant government ownership.
Astrazeneca Pharma India Ltd Shareholding Analysis Summary
The Astrazeneca Pharma India Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Astrazeneca Pharma India Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Astrazeneca Pharma India Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
